TrialThe Lancet. Infectious diseases2024

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.

Iman Satti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.